Table 1.
Characteristics of high-risk neuroblastoma patients enrolled on COG study ANBL00P1 (n = 41)
| Characteristic | Number | Percent (%) |
|---|---|---|
|
| ||
| Stratum | ||
| ISOLEX - Processed PBSC | 13 | 31.7 |
| MACS - Processed PBSC | 1 | 2.4 |
| Unselected PBSC | 27 | 65.9 |
|
| ||
| Age | ||
| < 12 months | 1 | 2.4 |
| 12 –<18 months | 5 | 12.2 |
| ≥ 18 months | 35 | 85.4 |
|
| ||
| Race | ||
| Black | 10 | 24.4 |
| White | 24 | 58.5 |
| Other | 4 | 9.8 |
| Unknown | 3 | 7.3 |
|
| ||
| Sex | ||
| Female | 17 | 41.5 |
| Male | 24 | 58.5 |
|
| ||
| INSS Stage | ||
| Stage 2B | 1 | 2.4 |
| Stage 3 | 3 | 7.3 |
| Stage 4 | 37 | 90.2 |
|
| ||
| MYCN | ||
| Amplified | 10 | 24.4 |
| Not Amplified | 24 | 58.5 |
| Unknown | 7 | 17.1 |
|
| ||
| Ploidy | ||
| Diploid | 18 | 43.9 |
| Hyperdiploid | 20 | 48.8 |
| Unknown | 3 | 7.3 |
|
| ||
| Shimada Histology | ||
| Favorable | 4 | 9.8 |
| Unfavorable | 25 | 61.0 |
| Unknown | 12 | 29.3 |
|
| ||
| Number of Transplants | ||
| None | 8 | 19.5 |
| Only one | 7 | 17.1 |
| Two | 26 | 63.4 |